PubRank

Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium

Clinical Trial ID NCT01783314

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01783314

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 10.25
2 Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000 9.07
3 Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 8.21
4 Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986 3.64
5 Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995 2.38
6 Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991 2.34
7 Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006 2.23
8 Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007 2.02
9 The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996 1.89
10 Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 2008 1.80
11 Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 2001 1.78
12 Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009 1.73
13 Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology 2008 1.62
14 Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995 1.36
15 Three-dimensional texture analysis of MRI brain datasets. IEEE Trans Med Imaging 2001 1.29
16 Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol 2008 1.29
17 Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 2005 1.17
18 Informatics in Radiology (infoRAD): Magnetic Resonance Imaging Workbench: analysis and visualization of dynamic contrast-enhanced MR imaging data. Radiographics 2006 1.12
19 Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983 1.12
20 Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol 2007 1.05
21 The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am J Respir Crit Care Med 2007 1.03
22 Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients. Eur Radiol 2011 1.02
23 Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology 2008 0.98
24 Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 1997 0.94
25 New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Eur J Radiol 2008 0.93
26 Imaging vascular physiology to monitor cancer treatment. Crit Rev Oncol Hematol 2006 0.92
27 Noninvasive markers of hepatic fibrosis: are they ready for prime time in the management of HIV/HCV co-infected patients? J Hepatol 2005 0.89
28 Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat 2009 0.88
29 Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 1999 0.87
30 Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging 2011 0.84
31 Experimental hepatic dysfunction: evaluation by MR imaging with Gd-EOB-DTPA. Acad Radiol 1998 0.83
32 Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients. J Viral Hepat 2006 0.83
33 [Transient elastography (Fibroscan), a new non-invasive method to evaluate hepatic fibrosis]. Med Clin (Barc) 2006 0.79
34 Magnetic resonance imaging. Liver-specific contrast agents. Clin Liver Dis 2002 0.77
35 Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis. Issues Emerg Health Technol 2006 0.77
36 Evaluation of Gd-EOB-DTPA uptake in a perfused and isolated mouse liver model: correlation between magnetic resonance imaging and monochromatic quantitative computed tomography. Invest Radiol 2005 0.75
Next 100